ITRM940322A0 - "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". - Google Patents

"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".

Info

Publication number: ITRM940322A0
Authority: IT; Italy
Prior art keywords: carbazolone; migraine; preparation; treatment; pharmaceutical composition
Prior art date: 1993-05-25

Application number

ITRM940322A

Other languages

English (en)

Inventor

Isabelle Thielemans

Isabelle Richard

Original Assignee

Glaxo Lab Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-05-25

Filing date

1994-05-24

Publication date

1994-05-24

1994-05-24 Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa

1994-05-24 Publication of ITRM940322A0 publication Critical patent/ITRM940322A0/it

1995-11-24 Publication of ITRM940322A1 publication Critical patent/ITRM940322A1/it

1997-07-01 Application granted granted Critical

1997-07-01 Publication of IT1272990B publication Critical patent/IT1272990B/it

Links

208000028017 Psychotic disease Diseases 0.000 title 1
AMLYRCOEFHJSFS-UHFFFAOYSA-N carbazol-1-one Chemical compound C1=CC=C2C3=CC=CC(=O)C3=NC2=C1 AMLYRCOEFHJSFS-UHFFFAOYSA-N 0.000 title 1
238000000034 method Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Otolaryngology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

ITRM940322A 1993-05-25 1994-05-24 "composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione". IT1272990B (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939310756A GB9310756D0 (en)	1993-05-25	1993-05-25	Compositions

Publications (3)

Publication Number	Publication Date
ITRM940322A0 true ITRM940322A0 (it)	1994-05-24
ITRM940322A1 ITRM940322A1 (it)	1995-11-24
IT1272990B IT1272990B (it)	1997-07-01

Family

ID=10736089

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ITRM940322A IT1272990B (it)	1993-05-25	1994-05-24	"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".

Country Status (38)

Country	Link
US (1)	US5741806A (it)
EP (1)	EP0700290B1 (it)
JP (1)	JP2965703B2 (it)
KR (1)	KR100297212B1 (it)
CN (1)	CN1106194C (it)
AP (1)	AP544A (it)
AT (1)	ATE183643T1 (it)
AU (1)	AU680918B2 (it)
BE (1)	BE1007158A3 (it)
BR (1)	BR1100046A (it)
CA (1)	CA2162919C (it)
CO (1)	CO4230094A1 (it)
CY (1)	CY2411B1 (it)
CZ (1)	CZ291041B6 (it)
DE (1)	DE69420266T2 (it)
DK (1)	DK0700290T3 (it)
EC (1)	ECSP941088A (it)
ES (1)	ES2136198T3 (it)
FR (1)	FR2705569B1 (it)
GB (2)	GB9310756D0 (it)
GR (1)	GR3031669T3 (it)
HR (2)	HRP940315B1 (it)
HU (1)	HU227121B1 (it)
IE (1)	IE80632B1 (it)
IL (1)	IL109749A (it)
IS (1)	IS1868B (it)
IT (1)	IT1272990B (it)
MY (1)	MY111445A (it)
NO (1)	NO306448B1 (it)
NZ (1)	NZ267415A (it)
PE (1)	PE13395A1 (it)
PL (1)	PL175578B1 (it)
RU (1)	RU2132684C1 (it)
SA (1)	SA94150003B1 (it)
SG (1)	SG48119A1 (it)
SI (1)	SI0700290T1 (it)
WO (1)	WO1994027599A1 (it)
ZA (1)	ZA943593B (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2003522103A (ja) *	1998-06-15	2003-07-22	セプラコアインコーポレーテッド	無呼吸、過食症およびその他の障害を治療するための光学的に純粋な（−）−ノルシスアプリドの使用
EP1468685A3 (en) *	1998-06-15	2004-12-15	Sepracor Inc.	Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders
EP1464333A3 (en) *	1998-06-15	2004-12-15	Sepracor Inc.	Use of optically pure (-) norcisapride in the treatment of apnea, bulimia, and other disorders
EP1089733B1 (en)	1998-06-15	2005-03-23	Sepracor Inc.	Use of optically pure (+)-norcisapride for treating irritable bowel syndrome
US6362202B1 (en)	1999-03-02	2002-03-26	Sepracor Inc.	Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists
US6353005B1 (en)	1999-03-02	2002-03-05	Sepracor, Inc.	Method and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonist
AU7931301A (en) *	2000-08-04	2002-02-18	Dmi Biosciences Inc	Method of using diketopiperazines and composition containing them

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR920003064B1 (ko) *	1984-01-25	1992-04-13	글락소 그룹 리미티드	헤테로시클릭 화합물의 제조방법
US4695578A (en) *	1984-01-25	1987-09-22	Glaxo Group Limited	1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
GB8627909D0 (en) *	1986-11-21	1986-12-31	Glaxo Group Ltd	Medicaments
GB8816187D0 (en) *	1988-07-07	1988-08-10	Glaxo Group Ltd	Medicaments
US5166145A (en) *	1990-09-10	1992-11-24	Alza Corporation	Antiemetic therapy

1993
- 1993-05-25 GB GB939310756A patent/GB9310756D0/en active Pending
1994
- 1994-05-17 EC EC1994001088A patent/ECSP941088A/es unknown
- 1994-05-17 GB GB9409835A patent/GB2279008B/en not_active Expired - Lifetime
- 1994-05-17 SG SG1996007139A patent/SG48119A1/en unknown
- 1994-05-19 IS IS4168A patent/IS1868B/is unknown
- 1994-05-20 MY MYPI94001305A patent/MY111445A/en unknown
- 1994-05-23 HR HR940315A patent/HRP940315B1/xx not_active IP Right Cessation
- 1994-05-23 AP APAP/P/1994/000643A patent/AP544A/en active
- 1994-05-23 CO CO94021615A patent/CO4230094A1/es unknown
- 1994-05-23 IE IE940420A patent/IE80632B1/en not_active IP Right Cessation
- 1994-05-23 PE PE1994242905A patent/PE13395A1/es not_active IP Right Cessation
- 1994-05-24 PL PL94311721A patent/PL175578B1/pl unknown
- 1994-05-24 US US08/537,950 patent/US5741806A/en not_active Expired - Lifetime
- 1994-05-24 AT AT94918355T patent/ATE183643T1/de active
- 1994-05-24 FR FR9406252A patent/FR2705569B1/fr not_active Expired - Lifetime
- 1994-05-24 KR KR1019950705280A patent/KR100297212B1/ko not_active IP Right Cessation
- 1994-05-24 RU RU95122578A patent/RU2132684C1/ru active
- 1994-05-24 IL IL10974994A patent/IL109749A/en not_active IP Right Cessation
- 1994-05-24 HU HU9503375A patent/HU227121B1/hu unknown
- 1994-05-24 IT ITRM940322A patent/IT1272990B/it active IP Right Grant
- 1994-05-24 SI SI9430263T patent/SI0700290T1/xx unknown
- 1994-05-24 ZA ZA943593A patent/ZA943593B/xx unknown
- 1994-05-24 WO PCT/EP1994/001652 patent/WO1994027599A1/en active IP Right Grant
- 1994-05-24 NZ NZ267415A patent/NZ267415A/en not_active IP Right Cessation
- 1994-05-24 CN CN94192243A patent/CN1106194C/zh not_active Expired - Lifetime
- 1994-05-24 DE DE69420266T patent/DE69420266T2/de not_active Expired - Lifetime
- 1994-05-24 BE BE9400528A patent/BE1007158A3/fr not_active IP Right Cessation
- 1994-05-24 DK DK94918355T patent/DK0700290T3/da active
- 1994-05-24 EP EP94918355A patent/EP0700290B1/en not_active Expired - Lifetime
- 1994-05-24 JP JP7500204A patent/JP2965703B2/ja not_active Expired - Lifetime
- 1994-05-24 AU AU69709/94A patent/AU680918B2/en not_active Expired
- 1994-05-24 ES ES94918355T patent/ES2136198T3/es not_active Expired - Lifetime
- 1994-05-24 CZ CZ19953085A patent/CZ291041B6/cs not_active IP Right Cessation
- 1994-05-24 CA CA002162919A patent/CA2162919C/en not_active Expired - Lifetime
- 1994-06-12 SA SA94150003A patent/SA94150003B1/ar unknown
1995
- 1995-11-24 NO NO954783A patent/NO306448B1/no not_active IP Right Cessation
1996
- 1996-09-19 BR BR1100046-5A patent/BR1100046A/pt active IP Right Grant
1997
- 1997-06-09 HR HR970315A patent/HRP970315A2/hr not_active Application Discontinuation
1999
- 1999-10-27 GR GR990402759T patent/GR3031669T3/el unknown
2000
- 2000-06-06 CY CY0000022A patent/CY2411B1/xx unknown

Also Published As

Publication number	Publication date
NO306448B1 (no)	1999-11-08
FR2705569B1 (fr)	1995-11-10
PL311721A1 (en)	1996-03-04
PL175578B1 (pl)	1999-01-29
DE69420266D1 (de)	1999-09-30
HRP940315A2 (en)	1996-08-31
NO954783L (no)	1995-11-24
IL109749A0 (en)	1994-08-26
AU680918B2 (en)	1997-08-14
FR2705569A1 (fr)	1994-12-02
DK0700290T3 (da)	2000-03-13
ITRM940322A1 (it)	1995-11-24
CA2162919C (en)	1999-07-20
GB2279008B (en)	1997-06-18
JPH08510457A (ja)	1996-11-05
NO954783D0 (no)	1995-11-24
IL109749A (en)	1999-03-12
EP0700290B1 (en)	1999-08-25
KR100297212B1 (ko)	2001-10-24
ATE183643T1 (de)	1999-09-15
MY111445A (en)	2000-05-31
CZ308595A3 (en)	1996-06-12
IT1272990B (it)	1997-07-01
SI0700290T1 (en)	1999-12-31
AP9400643A0 (en)	1994-07-31
HRP970315A2 (en)	1999-04-30
HRP940315B1 (en)	2000-12-31
ZA943593B (en)	1995-02-13
EP0700290A1 (en)	1996-03-13
BE1007158A3 (fr)	1995-04-11
AP544A (en)	1996-10-11
IE80632B1 (en)	1998-10-21
GB2279008A (en)	1994-12-21
JP2965703B2 (ja)	1999-10-18
BR1100046A (pt)	1999-11-23
HUT74867A (en)	1997-02-28
SG48119A1 (en)	1998-04-17
GR3031669T3 (en)	2000-02-29
CN1124454A (zh)	1996-06-12
NZ267415A (en)	1997-10-24
DE69420266T2 (de)	1999-12-09
ES2136198T3 (es)	1999-11-16
US5741806A (en)	1998-04-21
HU9503375D0 (en)	1996-01-29
GB9409835D0 (en)	1994-07-06
CN1106194C (zh)	2003-04-23
CO4230094A1 (es)	1995-10-19
PE13395A1 (es)	1995-05-25
CZ291041B6 (cs)	2002-12-11
IS4168A (is)	1994-11-26
RU2132684C1 (ru)	1999-07-10
AU6970994A (en)	1994-12-20
WO1994027599A1 (en)	1994-12-08
HU227121B1 (en)	2010-07-28
CA2162919A1 (en)	1994-12-08
CY2411B1 (en)	2004-11-12
IE940420A1 (en)	1994-11-30
SA94150003B1 (ar)	2005-04-11
IS1868B (is)	2003-05-02
GB9310756D0 (en)	1993-07-14
ECSP941088A (es)	1994-11-16

Legal Events

Date	Code	Title	Description
1997-07-01	0001	Granted
1999-10-27	TA	Fee payment date (situation as of event date), data collected since 19931001	Effective date: 19970530

Publication	Publication Date	Title
ITRM940325A0 (it)	1994-05-24	"composizioni stabilizzanti per la lavorazione delle materie polimere"
BR9406128A (pt)	1996-02-27	Uso de um composto processo para o tratamento e/ou prevençao de distúrbios psicóticos composto composiçao farmacêutica processos para a preparaçao de um composto e de uma composiçao farmacêutica
MX9704030A (es)	1998-02-28	1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
IT9048261A0 (it)	1990-09-07	Composizione farmaceutica per il trattamento di disturbi respiratori e metodo per la sua applicazione.
NO305903B1 (no)	1999-08-16	Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
PT754407E (pt)	2002-06-28	Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
IT1295645B1 (it)	1999-05-24	Apparecchio per l'elettroemanazione di principi attivi.
NO942303D0 (no)	1994-06-17	Farmasöytisk preparat, samt fremgangsmåte for fremstilling derav
FI974640A0 (fi)	1997-12-30	Migreenin hoitoon tarkoitetut 1,6-disubstituoidut isokromaanit
IT1292552B1 (it)	1999-02-08	Dispositivo per l'applicazione di rivestimenti.
MX9704034A (es)	1998-02-28	Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ITRM940322A0 (it)	1994-05-24	"composizione farmaceutica contenente carbazolone per il trattamento di emicrania e disturbi psicotici e relativo metodo di preparazione edapplicazione".
CA2135709A1 (en)	1995-05-19	Melatonin derivatives for use in treating sleep disorders
FR2718013B1 (fr)	1996-06-07	Dispositif d'enclouage centro-médullaire notamment pour fractures sous cervicales du fémur.
AU5053296A (en)	1996-10-17	Pharmaceutical agents for the treatment of Alzheimer's disease
IT1271567B (it)	1997-05-30	Procedimento per l'ulteriore trattamento di salcicce
ITMI932189A0 (it)	1993-10-15	Composizioni farmaceutiche contenenti n-acetilcarnosina per il trattamento della cataratta
IT1288399B1 (it)	1998-09-22	Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
AU5963396A (en)	1996-12-30	Cis-resorcylide, pharmaceutical composition containing it, use thereof in the treatment of thrombosis and related disorders
BR9610851A (pt)	1999-07-13	Composto processo de preparação de composto medicamento composição farmacêuticas e utilização do composto
IL110780A0 (en)	1994-11-11	Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold
BR9507732A (pt)	1997-08-19	Composição farmacêutica para o tratamento de glaucoma
ITRM940806A0 (it)	1994-12-15	Preparato per il trattamento dell'obesita'
IT1277117B1 (it)	1997-11-04	Composizioni farmaceutiche per il trattamento delle ipercolesterolemie
MX9704035A (es)	1998-02-28	1,1-dioxidos de 2-(fosfiniloximetil)-1,2,5-tiadiazolidin-3-ona substituidos y composiciones y metodo de uso de los mismos.